{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:04:19Z","timestamp":1779761059050,"version":"3.53.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Research Grants Council of the Hong Kong Special Administrative Region, China","award":["27112518"],"award-info":[{"award-number":["27112518"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04991-1","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:04:26Z","timestamp":1776261866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative performance of risk prediction models for kidney disease: an external validation using 0.5\u00a0million UK Biobank participants"],"prefix":"10.1186","volume":"27","author":[{"given":"Yikun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Hin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hin Lai Ivan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bishai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney C.W.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianchao","family":"Quan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"10440","key":"4991_CR1","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1016\/S0140-6736(24)00685-8","volume":"403","author":"SE Vollset","year":"2024","unstructured":"Vollset SE, Ababneh HS, Abate YH, Abbafati C, Abbasgholizadeh R, Abbasian M, et al. Burden of disease scenarios for 204 countries and territories, 2022\u20132050: a forecasting analysis for the Global Burden of Disease Study 2021. Lancet. 2024;403(10440):2204\u201356.","journal-title":"Lancet"},{"issue":"2","key":"4991_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/nrneph.2015.173","volume":"12","author":"MC Thomas","year":"2016","unstructured":"Thomas MC, Cooper ME, Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat Rev Nephrol. 2016;12(2):73\u201381.","journal-title":"Nat Rev Nephrol"},{"issue":"6","key":"4991_CR3","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1001\/jama.2016.10924","volume":"316","author":"M Afkarian","year":"2016","unstructured":"Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988\u20132014. JAMA. 2016;316(6):602\u201310.","journal-title":"JAMA"},{"issue":"6","key":"4991_CR4","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1007\/s13300-021-01050-w","volume":"12","author":"NS Skolnik","year":"2021","unstructured":"Skolnik NS, Style AJ. Importance of Early Screening and Diagnosis of Chronic Kidney Disease in Patients with Type 2 Diabetes. Diabetes Ther. 2021;12(6):1613\u201330.","journal-title":"Diabetes Ther"},{"key":"4991_CR5","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.5888\/pcd20.220380","volume":"20","author":"A Gonz\u00e1lez-Rocha","year":"2023","unstructured":"Gonz\u00e1lez-Rocha A, Colli VA, Denova-Guti\u00e9rrez E. Risk Prediction Score for Chronic Kidney Disease in Healthy Adults and Adults With Type 2 Diabetes: Systematic Review. Prev Chronic Dis. 2023;20:E30.","journal-title":"Prev Chronic Dis"},{"key":"4991_CR6","doi-asserted-by":"publisher","first-page":"n2134","DOI":"10.1136\/bmj.n2134","volume":"374","author":"RC Slieker","year":"2021","unstructured":"Slieker RC, van der Heijden AAWA, Siddiqui MK, Langendoen-Gort M, Nijpels G, Herings R, et al. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study. BMJ. 2021;374:n2134.","journal-title":"BMJ"},{"issue":"24","key":"4991_CR7","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1136\/heartjnl-2021-319243","volume":"107","author":"TA Buchan","year":"2021","unstructured":"Buchan TA, Malik A, Chan C, Chambers J, Suk Y, Zhu JW, et al. Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses. Heart. 2021;107(24):1962\u201373.","journal-title":"Heart"},{"issue":"4","key":"4991_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.2215\/CJN.07891109","volume":"5","author":"LC Plantinga","year":"2010","unstructured":"Plantinga LC, Crews DC, Coresh J, Miller ERI, Saran R, Yee J, et al. Prevalence of Chronic Kidney Disease in US Adults with Undiagnosed Diabetes or Prediabetes. Clin J Am Soc Nephrol. 2010;5(4):673.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"4991_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.amjmed.2010.05.010","volume":"123","author":"KL Chien","year":"2010","unstructured":"Chien KL, Lin HJ, Lee BC, Hsu HC, Lee YT, Chen MF. A Prediction Model for the Risk of Incident Chronic Kidney Disease. Am J Med. 2010;123(9):836\u2013e8462.","journal-title":"Am J Med"},{"issue":"22","key":"4991_CR10","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1001\/archinte.168.22.2466","volume":"168","author":"AV Kshirsagar","year":"2008","unstructured":"Kshirsagar AV, Bang H, Bomback AS, Vupputuri S, Shoham DA, Kern LM, et al. A Simple Algorithm to Predict Incident Kidney Disease. Arch Intern Med. 2008;168(22):2466\u201373.","journal-title":"Arch Intern Med"},{"issue":"21","key":"4991_CR11","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1001\/jama.2019.17379","volume":"322","author":"RG Nelson","year":"2019","unstructured":"Nelson RG, Grams ME, Ballew SH, Sang Y, Azizi F, Chadban SJ, et al. Development of Risk Prediction Equations for Incident Chronic Kidney Disease. JAMA. 2019;322(21):2104\u201314.","journal-title":"JAMA"},{"issue":"3","key":"4991_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.amjmed.2011.09.009","volume":"125","author":"CM O\u2019Seaghdha","year":"2012","unstructured":"O\u2019Seaghdha CM, Lyass A, Massaro JM, Meigs JB, Coresh J, D\u2019Agostino RB, et al. A Risk Score for Chronic Kidney Disease in the General Population. Am J Med. 2012;125(3):270\u20137.","journal-title":"Am J Med"},{"issue":"1","key":"4991_CR13","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12882-017-0653-z","volume":"18","author":"K Saranburut","year":"2017","unstructured":"Saranburut K, Vathesatogkit P, Thongmung N, Chittamma A, Vanavanan S, Tangstheanphan T, et al. Risk scores to predict decreased glomerular filtration rate at 10 years in an Asian general population. BMC Nephrol. 2017;18(1):240.","journal-title":"BMC Nephrol"},{"issue":"6","key":"4991_CR14","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1053\/j.ajkd.2017.09.013","volume":"71","author":"M Umesawa","year":"2018","unstructured":"Umesawa M, Sairenchi T, Haruyama Y, Nagao M, Yamagishi K, Irie F, et al. Validity of a Risk Prediction Equation for CKD After 10 Years of Follow-up in a Japanese Population: The Ibaraki Prefectural Health Study. Am J Kidney Dis. 2018;71(6):842\u201350.","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"4991_CR15","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.2215\/CJN.10321014","volume":"10","author":"D Dunkler","year":"2015","unstructured":"Dunkler D, Gao P, Lee SF, Heinze G, Clase CM, Tobe S, et al. Risk Prediction for Early CKD in Type 2 Diabetes. Clin J Am Soc Nephrol. 2015;10(8):1371\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4991_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.diabres.2016.11.008","volume":"123","author":"S Low","year":"2017","unstructured":"Low S, Lim SC, Zhang X, Zhou S, Yeoh LY, Liu YL, et al. Development and validation of a predictive model for Chronic Kidney Disease progression in Type 2 Diabetes Mellitus based on a 13-year study in Singapore. Diabetes Res Clin Pract. 2017;123:49\u201354.","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"4991_CR17","doi-asserted-by":"publisher","first-page":"e0120477","DOI":"10.1371\/journal.pone.0120477","volume":"10","author":"IJ Riphagen","year":"2015","unstructured":"Riphagen IJ, Kleefstra N, Drion I, Alkhalaf A, van Diepen M, Cao Q, et al. Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36). PLoS ONE. 2015;10(3):e0120477.","journal-title":"PLoS ONE"},{"issue":"9","key":"4991_CR18","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","volume":"56","author":"AJ Hayes","year":"2013","unstructured":"Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM. UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82. Diabetologia. 2013;56(9):1925\u201333.","journal-title":"Diabetologia"},{"issue":"5","key":"4991_CR19","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1053\/j.ajkd.2012.04.025","volume":"60","author":"MJ Jardine","year":"2012","unstructured":"Jardine MJ, Hata J, Woodward M, Perkovic V, Ninomiya T, Arima H, et al. Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes. Am J Kidney Dis. 2012;60(5):770\u20138.","journal-title":"Am J Kidney Dis"},{"issue":"10","key":"4991_CR20","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S2213-8587(17)30221-8","volume":"5","author":"S Basu","year":"2017","unstructured":"Basu S, Sussman JB, Berkowitz SA, Hayward RA, Yudkin JS. Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials. Lancet Diabetes Endocrinol. 2017;5(10):788\u201398.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"4991_CR21","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12882-017-0671-x","volume":"18","author":"EYF Wan","year":"2017","unstructured":"Wan EYF, Fong DYT, Fung CSC, Yu EYT, Chin WY, Chan AKC, et al. Prediction of new onset of end stage renal disease in Chinese patients with type 2 diabetes mellitus \u2013 a population-based retrospective cohort study. BMC Nephrol. 2017;18(1):257.","journal-title":"BMC Nephrol"},{"issue":"10","key":"4991_CR22","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.2337\/dc13-0190","volume":"36","author":"CR Elley","year":"2013","unstructured":"Elley CR, Robinson T, Moyes SA, Kenealy T, Collins J, Robinson E, et al. Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes. Diabetes Care. 2013;36(10):3113\u201320.","journal-title":"Diabetes Care"},{"key":"4991_CR23","unstructured":"UK Biobank - UK Biobank [Internet]. [cited 2021 May 14]. Available from: https:\/\/www.ukbiobank.ac.uk\/"},{"key":"4991_CR24","unstructured":"UK Biobank. Data providers and dates of data availability [Internet]. [cited 2024 Dec 23]. Available from: https:\/\/biobank.ndph.ox.ac.uk\/showcase\/exinfo.cgi?src=Data_providers_and_dates"},{"key":"4991_CR25","unstructured":"Radcliffe Department of Medicine. UKPDS Outcomes Model V2 (OM2.) [Internet]. [cited 2023 Oct 31]. Available from: https:\/\/www.rdm.ox.ac.uk\/about\/our-clinical-facilities-and-mrc-units\/DTU\/software\/outcomes"},{"issue":"9","key":"4991_CR26","doi-asserted-by":"publisher","first-page":"030006052110448","DOI":"10.1177\/03000605211044892","volume":"49","author":"H Liu","year":"2021","unstructured":"Liu H, Zhang L, Xu F, Li S, Wang Z, Han D, et al. Establishment of a prognostic model for patients with sepsis based on SOFA: a retrospective cohort study. J Int Med Res. 2021;49(9):03000605211044892.","journal-title":"J Int Med Res"},{"issue":"1","key":"4991_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13047-023-00610-6","volume":"16","author":"AS Kaka","year":"2023","unstructured":"Kaka AS, Landsteiner A, Ensrud KE, Logan B, Sowerby C, Ullman K, et al. Risk prediction models for diabetic foot ulcer development or amputation: a review of reviews. J Foot Ankle Res. 2023;16(1):13.","journal-title":"J Foot Ankle Res"},{"issue":"1","key":"4991_CR28","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","volume":"21","author":"EW Steyerberg","year":"2010","unstructured":"Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, et al. Assessing the Performance of Prediction Models: A Framework for Traditional and Novel Measures. Epidemiology. 2010;21(1):128.","journal-title":"Epidemiology"},{"issue":"1","key":"4991_CR29","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12963-025-00364-2","volume":"23","author":"KP Junaid","year":"2025","unstructured":"Junaid KP, Kiran T, Gupta M, Kishore K, Siwatch S. How much missing data is too much to impute for longitudinal health indicators? A preliminary guideline for the choice of the extent of missing proportion to impute with multiple imputation by chained equations. Popul Health Metrics. 2025;23(1):2.","journal-title":"Popul Health Metrics"},{"key":"4991_CR30","unstructured":"Statistical Analysis with Missing Data -, Roderick JA, Little DB, Rubin. - Google Book [Internet]. [cited 2025 Feb 7]. Available from: https:\/\/books.google.com.hk\/books?hl=zh-CN&lr=&id=BemMDwAAQBAJ&oi=fnd&pg=PR11&dq=Roderick+J.+A.+Little+DBR.+Statistical+Analysis+with+Missing+Data,+2nd+Edition.&ots=FCBWa2GY_U&sig=4JZcc_ko5CUObzxWYrZ1Ej3Z2bA&redir_esc=y#v=onepage&q&f=false"},{"key":"4991_CR31","unstructured":"Jr FEH, Hmisc: Harrell Miscellaneous [Internet]. 2023 [cited 2023 Mar 22]. Available from: https:\/\/CRAN.R-project.org\/package=Hmisc"},{"key":"4991_CR32","unstructured":"van Buuren S, Groothuis-Oudshoorn K, Vink G, Schouten R, Robitzsch A, Rockenschaub P et al. mice: Multivariate Imputation by Chained Equations [Internet]. 2024 [cited 2025 Feb 7]. Available from: https:\/\/cran.r-project.org\/web\/packages\/mice\/index.html"},{"issue":"4","key":"4991_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/pds.5398","volume":"31","author":"JM Paik","year":"2022","unstructured":"Paik JM, Patorno E, Zhuo M, Bessette LG, York C, Gautam N, et al. Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data. Pharmacoepidemiol Drug Saf. 2022;31(4):467\u201375.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"4","key":"4991_CR34","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/S0085-2538(24)00123-6","volume":"105","author":"KDIGO EXECUTIVE COMMITTEE","year":"2024","unstructured":"KDIGO EXECUTIVE COMMITTEE. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2024;105(4):A1.","journal-title":"Kidney Int"},{"issue":"3","key":"4991_CR35","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/imj.13729","volume":"48","author":"S Ko","year":"2018","unstructured":"Ko S, Venkatesan S, Nand K, Levidiotis V, Nelson C, Janus E. International statistical classification of diseases and related health problems coding underestimates the incidence and prevalence of acute kidney injury and chronic kidney disease in general medical patients. Intern Med J. 2018;48(3):310\u20135.","journal-title":"Intern Med J"},{"issue":"6","key":"4991_CR36","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/ki.2014.112","volume":"86","author":"F James","year":"2014","unstructured":"James F, Nicholas W, Bisher K, Damian F, Timothy E. The body composition and excretory burden of lean, obese, and severely obese individuals has implications for the assessment of chronic kidney disease. Kidney Int. 2014;86(6):1221\u20138. https:\/\/doi.org\/10.1038\/ki.2014.112.","journal-title":"Kidney Int"},{"issue":"3","key":"4991_CR37","doi-asserted-by":"publisher","first-page":"e382","DOI":"10.1016\/S2214-109X(23)00570-3","volume":"12","author":"AK Bello","year":"2024","unstructured":"Bello AK, Okpechi IG, Levin A, Ye F, Damster S, Arruebo S, et al. An update on the global disparities in kidney disease burden and care across world countries and regions. Lancet Global Health. 2024;12(3):e382\u201395.","journal-title":"Lancet Global Health"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04991-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04991-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04991-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:53:12Z","timestamp":1779760392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04991-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4991"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04991-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and received ethical approval from the Institutional Review Board of the University of Hong Kong (UW 21\u2013414). All data utilized in this study were obtained from the UK Biobank Resource. The UK Biobank has received Research Tissue Bank approval from the Northwest Multi-centre Research Ethics Committee (ID: 16\/NW\/0274). All participants provided informed consent electronically at the time of recruitment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}